28
Views
4
CrossRef citations to date
0
Altmetric
Letters to the Editor

Prediction of response to imatinib in patients with chronic myelogenous leukemia by flow cytometric analysis of bone marrow blastic cell phenotypes

, , MD, , , , , , , , , , , & show all
Pages 290-293 | Received 06 Sep 2008, Accepted 15 Nov 2008, Published online: 01 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Ikhwan Rinaldi & Kevin Winston. (2023) Chronic Myeloid Leukemia, from Pathophysiology to Treatment-Free Remission: A Narrative Literature Review. Journal of Blood Medicine 14, pages 261-277.
Read now

Articles from other publishers (3)

Nur OGUZ DAVUTOGLU, Eren GUNDUZ, Fatih YAMAN, Serap ARSLAN, Oğuz ÇİLİNGİR, Sevgi IŞIK & Beyhan DURAK ARAS. (2021) Flow Cytometric Analysis of Chronic Phase Chronic Myeloid Leukemia Patients. OSMANGAZİ JOURNAL OF MEDICINE.
Crossref
Satoko Oka, Kazuo Muroi, Shin-ichiro Fujiwara, Iekuni Oh, Tomohiro Matsuyama, Ken Ohmine, Takahiro Suzuki, Katsutoshi Ozaki, Masaki Mori, Tadashi Nagai, Keiya Ozawa & Toshiaki Hanafusa. (2012) Prediction of Progression from Refractory Cytopenia with Unilineage Dysplasia by Analysis of Bone Marrow Blast Cell Composition. Journal of Clinical and Experimental Hematopathology 52:1, pages 63-66.
Crossref
Claudio Ortolani. 2011. Flow Cytometry of Hematological Malignancies. Flow Cytometry of Hematological Malignancies 160 300 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.